•  



RELATIONSHIP BETWEEN VITAMIN D3 AND DISEASE ACTIVITY IN IRAQI PATIENTS WITH ANKYLOSING SPONDYLITISAND THOSE TREATED BY INFLIXIMAB SPONDYLITISAND THOSE TREATED BY INFLIXIMAB FLIXIMAB
Authors : Munaf Salih Daoud1 *, Nizar Abdulateef Jassim² and Najat Sadeq Hasan1
Background: In medicine, a 25-hydroxy vitamin D (calcidiol) blood test is used to determine how much vitamin D is in the body. The blood concentration of calcidiol is considered the best indicator of vitamin D status. It is the most sensitive measure, though experts have called for improved standardization and reproducibility across different laboratories , the normal range of calcidiol is 30.0 to 74.0 ng/mL. Objective: To evaluate vitamin D3 in iraqi patients with ankylosingspondylitis ,and represent its affect on disease activity. Material and methods: Eighty five AS patients are enrolled in this study with a mean age of 36 ± 41 years & age range from 16-56 years , mean duration equal to 12.08. Results: There was a slightly non significant increase of mean serum level of vitamin D3 in G2 & G3 ( 24.26 ± 16.51 ng/ml , p = 0.914 , 24.28 ± 16.16 ng/ml , p = 0.912 ) respectively compared with it in G1 (23.79 ± 14.00 ng/ml ). This represented in table 3.2 . There is a highly significant decrease of mean ± SD of BASFI & BASDAI in G2 & G3 (5.87 ± 1.13 , 3.34 ± 0.585, P < 0.001 , 3.34 ± 0.78 , 1.35 ± 0.66 , P < 0.001) respectively compared in G1 (7.91 ± 0.78 , 5.51 ± 0.79) . Conclusion: Serum vitamin D levels can decrease in AS patients due to both nutritional deficiency and inadequate exposure to sunlight, or for etiopathogenetic reasons. They also led us to the conslusion that insufficiency of vitamin D may cause increased disease activity and fatigue, and decreased functional capacity and quality of life.

(FULL ARTICLE LINK) Read more ...
25/10/2014